US Futures Gain as Quarterly Results Beat Views; Home Prices Gain as Expected

By Staff,

Shutterstock photo

U.S. stock futures were moving higher Tuesday after companies reported better-than-expected quarterly results and as home prices in February were as expected.

The home price index rose 0.8% in February, equal to Bloomberg's consensus. At 10:00 a.m., the Conference Board's consumer confidence index is seen rising to 83.0 for April from 82.3 in March.

The Federal Open Market Committee's two-day meeting starts today. The FOMC will make an announcement Wednesday at 2:00 p.m.

In equities, Merck ( MRK ) edged higher over 1% in recent pre-market trade after reporting higher than expected EPS even as revenue missed the consensus. The pharmaceutical company reaffirmed its FY guidance. Sprint ( S ) also gained nearly 3% pre-bell after a narrower-than-expected loss. Meanwhile, NorthStar Realty Finance ( NRF ) fell over 8% after saying it is not in merger talks with American Realty Capital Properties ( ARCP ). ARCP was up 3%.


-Dow Jones Industrial up 0.23%

-S&P 500 futures up 0.25%

-Nasdaq 100 futures up 0.21%

-Nasdaq-100 Pre-Market Indicator down 0.34%


Nikkei down 0.98%

Hang Seng up 1.45%

Shanghai Composite up 1.45%

FTSE-100 up 0.78%

DAX-30 up 1.21%


(+/-) Large cap tech: mixed

(+) Chip stocks: unchanged to higher

(+) Software stocks: unchanged to higher

(+) Hardware stocks: unchanged to higher

(+/-) Internet stocks: mixed

(+/-) Drug stocks: mixed

(+) Financial stocks: unchanged to higher

(+/-) Retail stocks: mixed

(+) Industrial stocks: unchanged to higher

(+) Airlines: unchanged to higher

(+) Autos: unchanged to higher


(+) NOK (+5.3%) Reports Q1 profit, names Rajeev Suri CEO

(+) SCOR (+2.2%) Q1 tops expectations

(+) CMI (+3.3%) Q1 results beat forecasts, raises revenue guidance

(+) MGM (+3.4%) Q1 exceeds views

(+) STM (+2.5%) Q1 matches expectations, gives Q2 sales guidance

(+) HW (+5.0%) Reports better-than-expected fiscal Q2 results

(+) DIS (+0.8%) Said to eye Buzzfeed, talks broke down on $1 bln valuation

(+) FOLD (+22.8%) Reports positive data from Fabry monotherapy drug study

(+) NVAX (+7.9%) Reports positive data from RSV-F protein nanoparticle vaccine candidate

(+) YHOO (+1.1%) Partners with comscore to expand ad measurement access


(-) GT (-4.9%) Q1 misses views

(-) GOGO (-15.7%) AT&T plans rival inflight wireless service

(-) OIBR (-9.4%) Plans sale of shares

(-) DDD (-5.7%) Q1 EPS just shy of views

(-) COH (+8.9%) Fiscal Q3 earnings beats views, shy on sales

(-) FLML (-14.4%) FDA doesn't approve Eclat NDA on supplier manufacturing issues

(-) ABB (-7.0%) Posts Q1 miss

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: MRK , S , NRF , ARCP

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by